Fig. 1. Study overview.
Cellformer was fed data from comorbidity-free bulk samples from individuals with clinicopathologic characterization as normal control (NC), Resilient to Alzheimer’s disease (RAD), and Alzheimer’s disease dementia (ADD). Three brain regions were used per individual to gain insight into the regional and cellular epigenetic profile of RAD. Cellformer generated cell type-specific expression for 6 main cell types across the whole genome, leading to an unprecedented chromatin profiling of RAD (Created with Biorender.com).